AI in Healthcare Series: Have We Already Bent the Healthcare Cost Curve?

AI in Healthcare Series: Have We Already Bent the Healthcare Cost Curve? — Stanford Online

Stanford Online

AI-assisted summary of AI in Healthcare Series: Have We Already Bent the Healthcare Cost Curve? — original source. Check the original for full context.

Source published:

Key ideas

  • Economic analysis by Cutler and Klarnet reveals that 2024 U.S. healthcare spending landed at 18.0% of GDP ($5.3 trillion) rather than the 21.2% ($6.3 trillion) projected by CMS in 2010, generating an unexpected $977 billion savings in 2024 and $6.7 trillion cumulatively over 14 years. (34:19)
  • The U.S. healthcare system spends $3.2 trillion on labor across 23.8 million workers, but the industrialization of clinical cognition threatens up to 50% of entry-level healthcare jobs as autonomous AI drives the marginal cost of expertise toward zero. (11:45)
  • More than $1 trillion in hospital physical assets faces structural obsolescence as generative AI decouples clinical reasoning from geographic co-location, removing the original economic justification for centralized specialty facilities. (19:30)
  • Healthcare is confronting a ten-year implementation overhang: existing foundation models already provide more than enough cognitive capability to drive radical workflow transformations without waiting for future algorithmic breakthroughs. (31:21)

Detailed notes

## Background Published on YouTube by Stanford Online on September 24, 2026, this episode of the Stanford Healthcare AI Podcast features hosts Matt Lungren and Justin Norden speaking with Eric Larsen, President at TowerBrook Advisors and venture partner at Thrive Capital and SignalFire. According to the show description, the discussion explores whether AI has already begun bending the U.S. healthcare cost curve, debating autonomous clinical AI, the displacement of prestige professions, site-of-care shifts, GLP-1s, and a paper suggesting nearly $1 trillion in unexpected savings.

## TL;DR The panel explores the provocative thesis that autonomous AI is beginning to outperform physicians, drawing parallels to competitive chess where pairing humans with machines eventually degraded pure algorithmic accuracy. Eric Larsen argues that AI will transform clinical expertise from an artificially scarce commodity into an abundant resource, threatening the multi-trillion-dollar economic model of traditional hospital real estate and medical guilds. The hosts highlight the agility of insurgent tools like Cursor against legacy incumbents, debating headless EHR architectures and emphasizing a decade-long implementation overhang that already exists with current models. Finally, the discussion examines economic data demonstrating that U.S. healthcare spending diverged nearly $1 trillion below 2010 projections even before AI deployment, showing that pairing historical site-of-care precedents and GLP-1 therapies with cognitive abundance could drive unprecedented deflation.

## Atmosphere & style The conversation carries an urgent, rapid-fire, and intellectually subversive tone, balancing private equity realism with frontline clinical depth. Larsen speaks with unvarnished, provocative conviction, weaving between historical analogies like Garry Kasparov and institutional critique, while Lungren and Norden act as nuanced, analytical counterweights. The dynamic feels like an unfiltered strategy session among industry insiders who have moved past initial skepticism and are actively charting the collapse of legacy healthcare hierarchies with sharp humor and profound optimism.

## Bulletin - [34:19](https://www.youtube.com/watch?v=pUF0o57YdL8&t=2059s) Economic analysis by Cutler and Klarnet reveals that 2024 U.S. healthcare spending landed at 18.0% of GDP ($5.3 trillion) rather than the 21.2% ($6.3 trillion) projected by CMS in 2010, generating an unexpected $977 billion savings in 2024 and $6.7 trillion cumulatively over 14 years. - [11:45](https://www.youtube.com/watch?v=pUF0o57YdL8&t=705s) The U.S. healthcare system spends $3.2 trillion on labor across 23.8 million workers, but the industrialization of clinical cognition threatens up to 50% of entry-level healthcare jobs as autonomous AI drives the marginal cost of expertise toward zero. - [19:30](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1170s) More than $1 trillion in hospital physical assets faces structural obsolescence as generative AI decouples clinical reasoning from geographic co-location, removing the original economic justification for centralized specialty facilities. - [31:21](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1881s) Healthcare is confronting a ten-year implementation overhang: existing foundation models already provide more than enough cognitive capability to drive radical workflow transformations without waiting for future algorithmic breakthroughs.

## Key takeaways - [00:12](https://www.youtube.com/watch?v=pUF0o57YdL8&t=12s) A controversial meta-analysis by Ezekiel Emanuel, Neal Khosla, and Vinod Khosla argues that autonomous AI outperforms physicians across multiple cognitive tasks, drawing fierce pushback over proposals to deploy models without human oversight. - [01:28](https://www.youtube.com/watch?v=pUF0o57YdL8&t=88s) Bob Wachter's 'Doorman Problem' illustrates that outperforming humans on narrow clinical benchmarks, such as pneumonia detection, does not capture the dozens of diverse interpersonal, physical, and cognitive micro-tasks required in routine medical practice. - [04:17](https://www.youtube.com/watch?v=pUF0o57YdL8&t=257s) Healthcare mirrors the evolution of competitive chess, transitioning from human dominance to 'centaur' human-machine teaming, and eventually to autonomous AI superiority where superimposing human judgment actively degrades output accuracy. - [08:57](https://www.youtube.com/watch?v=pUF0o57YdL8&t=537s) Established medical guilds follow Elting Morison's classic four-stage response to disruptive technology—shifting from denial to pedantic methodological rebuttals, launching ad hominem attacks, and finally facing forced institutional adaptation. - [11:45](https://www.youtube.com/watch?v=pUF0o57YdL8&t=705s) The $6 trillion U.S. healthcare model is organized around cognitive scarcity created by prolonged medical training, but synthetic intelligence demonetizes this scarcity by drastically lowering the cost of expert clinical reasoning. - [17:01](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1021s) The success of Cursor over Microsoft illustrates how agile, unencumbered insurgents can outmaneuver massive incumbents burdened by legacy coordination overhead, providing a blueprint for AI-native healthcare delivery. - [17:01](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1021s) Academic medicine's protracted multi-year peer review and curriculum cycles operate too slowly to evaluate foundational AI models that iterate on weekly and monthly cycles. - [19:30](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1170s) Sprawling hospital campuses housing $1 trillion in real estate exist primarily to co-locate fragmented subspecialists under one roof, an architectural need that disappears once personal AI equips individuals with polymath-level expertise. - [22:58](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1378s) The rapid acceleration of medical knowledge—collapsing from a 50-year doubling time in 1950 to 73 days by 2019—forced doctors into hyper-subspecialization that only automated intelligence can coherently synthesize. - [29:22](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1762s) To survive disruption, electronic health record incumbents like Epic and Oracle must transition into headless systems of record designed for agent-to-agent transactions rather than human graphical interfaces. - [33:00](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1980s) Healthcare has historically suffered from Baumol's cost disease because wages consistently rose without corresponding clinical productivity gains, a dynamic AI breaks by industrializing and scaling cognitive labor. - [37:03](https://www.youtube.com/watch?v=pUF0o57YdL8&t=2223s) Pre-AI structural levers—such as moving joint replacements to outpatient settings to save $94 billion in 2024 and GLP-1 therapies reducing employer spend by 5% at eMed—demonstrate that healthcare has already begun an unprecedented downward cost curve inflection.

## Detailed walkthrough ### [00:12](https://www.youtube.com/watch?v=pUF0o57YdL8&t=12s) Introduction and the Provocative Khosla-Emanuel Thesis

Justin Norden welcomes listeners back to the Stanford Healthcare AI Podcast, introducing guest Eric Larsen. Larsen brings more than 25 years of healthcare experience as the president of TowerBrook Advisors, venture partner at both Thrive Capital and SignalFire, an investor in Qualified Health, and the former president of The Advisory Board Company. Norden describes Larsen as widely recognized across the industry as the "whisperer to what is coming next in healthcare."

```mermaid flowchart TD accTitle: Evolution of Human-AI Synergy in Functional Domains accDescr: Progression from human dominance to the centaur model to pure autonomous machine superiority, modeled after chess. subgraph S1["Human Dominance"] A["Pre-1997: Human Apex"] end subgraph S2["Epistemic Shock & Collaboration"] B["1997: Deep Blue defeats Kasparov"] C["2005–2012: The Centaur Era<br/>(Human + Machine beats either alone)"] end subgraph S3["Machine Superiority"] D["Post-2012: Pure Machine Dominance<br/>(AI alone exceeds Centaur)"] E["Healthcare Cognitive Tasks:<br/>Superimposing human judgment degrades AI accuracy"] end A --> B B --> C C --> D D --> E ```

Norden immediately steers the discussion into one of the most polarizing and widely publicized recent healthcare publications: an opinion paper authored by Ezekiel "Zeke" Emanuel, Neal Khosla, and Vinod Khosla arguing that autonomous artificial intelligence has begun to demonstrably exceed human physicians. Turning to co-host Matt Lungren, the practicing radiologist on the panel, Norden asks for an initial clinical assessment of the provocative claim.

[01:28](https://www.youtube.com/watch?v=pUF0o57YdL8&t=88s) The "Doorman Problem" and the Limits of Current Benchmarks

Matt Lungren acknowledges that anyone in the digital health community who has not been living under a rock has spent the past few weeks reading and debating the Emanuel-Khosla paper. While conceding that the authors selected provocative data points to anchor an opinion piece, Lungren notes that it is grounded in real academic findings: across numerous benchmarked clinical tasks, autonomous AI frequently outperforms clinicians, and pairing an AI with a physician surprisingly yields worse results than letting the AI run alone. The extreme logical conclusion drawn by the authors—that AI should simply be deployed to deliver patient care autonomously—is what has triggered fierce backlash.

Aligning his own view closely with a Substack response written by Bob Wachter, Lungren points to what Wachter termed "the Doorman Problem." Narrow benchmarks can make an algorithm look entirely superior—in radiology, a model might outperform a human on pneumonia detection, but pneumonia detection accounts for just 1% of a radiologist's daily job. Citing a lecture by clinician and AI researcher Graham, Lungren argues that shadowing any practicing doctor for five minutes reveals nearly twenty distinct physical, interpersonal, and cognitive micro-tasks that benchmarks cannot capture. While administrators and builders have heavily emphasized automating mundane administrative workflows, Lungren stresses that current benchmarks merely reflect hill-climbing on narrow tasks rather than the reality of broad clinical care.

[04:17](https://www.youtube.com/watch?v=pUF0o57YdL8&t=257s) From Centaurs to Autonomous AI: Lessons from Chess and Scarcity

Eric Larsen approaches the topic with non-clinician humility, yet strongly defends the thesis of the Emanuel-Khosla piece. Larsen reflects on Vinod Khosla’s track record, calling him perhaps the most clairvoyant technologist of the past 75 years alongside Ray Kurzweil. When Khosla wrote *Dr. Algorithm: The 20% Doctor* in 2016, his incendiary predictions sparked immense outrage. Although Khosla has since softened into a far more diplomatic and measured communicator, Larsen argues that this latest meta-analysis demonstrates that across five distinct cognitive domains, AI provides demonstrably superior fidelity to ground truth than human practitioners.

To illustrate why human-in-the-loop workflows may degrade accuracy, Larsen draws a direct parallel to the history of competitive chess:

- **1997 Epistemic Shock:** Garry Kasparov fell to IBM's Deep Blue, overturning the assumption that human intuition reigned supreme. - **2005–2012 "Centaur" Period:** Kasparov documented that human grandmasters collaborating with chess engines ("centaurs") consistently outperformed pure engines or lone humans. - **Post-2012 Machine Dominance:** Chess models advanced to the point where superimposing human tactical judgment actively degraded the computer's moves. - **The Codification of Tacit Knowledge:** Citing recent research by Stanford economist Erik Brynjolfsson on autonomous driving, Larsen notes that "embodied" or tacit tribal knowledge is increasingly learnable by synthetic intelligences.

Larsen contends that the entire organization of the $6 trillion U.S. healthcare sector is founded on cognitive scarcity—the reality that training a radiologist requires 12 years and $250,000 of debt, leaving supply inelastic. In Larsen's view, a synthetic "Jupiter brain" is about to systematically dislocate prestige professions across the board, signaling to humanity: "Get ready. You are not the apex predator."

[08:57](https://www.youtube.com/watch?v=pUF0o57YdL8&t=537s) Delusional Exponentials and the Elting Morison Playbook

Lungren responds by emphasizing the cognitive trap of debating current static capabilities rather than exponential trajectories. Recalling his public health training and the early spread of COVID-19, Lungren compares today's incremental debates to the initial impulse to stop cruise ships from docking: leaders acted as if isolating individual cases would prevent spread, entirely missing that the transmission rate ($R_0$) had already made an exponential explosion inevitable. To Lungren, leaders are not "thinking delusional enough" about the slope of algorithmic acceleration, which makes society-wide institutional reorganization urgent.

```mermaid flowchart TD accTitle: Elting Morison's Societal Response to Radical Technology accDescr: The four stages societies pass through when facing disruptive innovations according to Elting Morison. Step1["1. Ignore the technology"] --> Step2["2. Attempt rational rebuttal"] Step2 --> Step3["3. Mock champions with ad hominem attacks"] Step3 --> Step4["4. Adaptation forced by outside moral authority"] ```

Larsen agrees, referencing MIT historian Elting Morison’s classic 1955 work *Men, Machines, and Modern Times*. Morison observed that when confronted by radical technological shifts, legacy institutions pass through four predictable stages:

1. **Ignorance:** The incumbent establishment ignores the development entirely. 2. **Rational Rebuttal:** The establishment attempts to dismantle the technology using orthodox logic. 3. **Mockery and Ad Hominem:** Incumbents ridicule the technology and attack the character of its champions. 4. **Forced Adaptation:** Meaningful change only occurs when an outside leader possessing sufficient moral authority and executive energy overrides the incumbents.

Larsen observes that high-prestige guilds—medicine, law, management consulting, and finance—are currently watching their primacy and historic social hierarchies threatened by autonomous cognition, and are reacting precisely according to Morison's playbook.

[11:45](https://www.youtube.com/watch?v=pUF0o57YdL8&t=705s) The Guilds' Backlash and the Demise of Scarcity

Eric Larsen dissects the predictable, formulaic defense mounted by established medical guilds whenever autonomous artificial intelligence threatens their authority. He identifies a distinct three-stage reaction: initial denial (which the industry has mostly moved past), followed by hyper-pedantic "rational rebuttals"—often dismissing groundbreaking work by complaining that authors "cited the wrong study" or omitted a methodology section—and culminating in ad hominem attacks. Critics point fingers at billionaires pushing agendas or highlight family connections, such as venture capitalist Vinod Khosla championing his son Neal Khosla’s AI company, Curai Health. Yet, Larsen points out that pairing the technological vision of Vinod Khosla with the clinical and ethical credibility of Ezekiel Emanuel creates a formidable challenge that the traditional hierarchy cannot easily brush aside.

At its core, this resistance reflects a profound cultural and philosophical disruption. In modern secular society, human intellect has been deified at the very summit of the hierarchy. For the first time, humanity has "speciated something" that rivals human capability across fundamental cognitive dimensions and outright surpasses human performance in emerging clinical functions. This sudden shift destroys the economic premise of scarcity that underpins high-prestige white-collar work: when medical cognition is no longer scarce, the profession inherently demonetizes, driving the marginal cost of clinical intelligence toward zero.

Larsen recalls challenging Anthropic CEO Dario Amodei on this very dilemma, pressing him on how society will handle the displacement of healthcare workers when 23.8 million Americans work in the industry, and projections suggest a 50% dislocation of entry-level jobs alongside 10% to 20% overall unemployment. Amodei’s candid, patient-first response was revealing: *"I don't know. I'm thinking about the patient."*

- **The Three Stages of Guild Resistance**: 1. *Ignoring*: Attempting to overlook the encroaching technology until it becomes impossible to disregard. 2. *Rationalizing*: Nitpicking methodology, citations, and trial designs to disqualify uncomfortable conclusions. 3. *Ad Hominem*: Mocking tech billionaires, alleging conflicts of interest, and questioning commercial motives. - **Economic Disruption Scale**: 23.8 million Americans are employed across the U.S. healthcare sector, facing potential 50% entry-level dislocation as cognitive tasks automate.

---

[13:54](https://www.youtube.com/watch?v=pUF0o57YdL8&t=834s) High-Stakes Bets and Healthcare's Oppenheimer Moment

Justin Norden steps in to frame his role as the provocateur between two leaders who understand the nuances of the legacy system while remaining deeply "AI-pilled." He recounts a debate held with Ezekiel Emanuel roughly a year earlier, where the two attempted to settle on a concrete wager—jokingly stakes as high as "a chocolate bar"—to define how they could quantitatively prove AI’s superiority in patient outcomes or cost reduction. At the time, defining that metric seemed challenging; yet within twelve months, Emanuel’s own stance dramatically evolved toward recognizing the sheer power and inevitability of autonomous clinical tools.

The blistering pace of technological change creates an acute dilemma for advisors and operators. Norden notes that Larsen published a sweeping essay titled *Healthcare’s Oppenheimer Moment* only two months prior, yet parts of the analysis already feel dated. When Norden works with hospital executives through Qualified Health, he finds himself walking a strategic tightrope: describing the actual trajectory of AI risks alienating health system leaders who, even if personally convinced, cannot persuade conservative boards to greenlight the necessary speed and capital. He challenges Larsen and Lungren to cast aside diplomatic caveats and articulate where the frontier is truly headed.

---

[17:01](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1021s) The Cursor Paradigm: Insurgents vs. Legacy Healthcare Systems

Matt Lungren argues that forecasting in the AI era inevitably sounds delusional because linear intuition fails when applied to exponential curves. The fundamental question is whether entrenched institutions are structurally capable of leveraging these capabilities. In lower-risk, less regulated sectors, tiny seven-person teams wielding modern AI tooling are already outmaneuvering tech conglomerates. The defining case study is Cursor: in 2024, Microsoft held every structural advantage—exclusive access to OpenAI IP, ownership of GitHub, and Visual Studio Code, the most dominant integrated development environment (IDE) on Earth. Yet a small, unencumbered startup built a superior AI coding harness on top of underlying foundation models and captured the developer market.

```mermaid flowchart TD accTitle: Incumbent Advantage vs Insurgent Velocity accDescr: A diagram comparing Microsoft's entrenched software assets against Cursor's lean, use-case-focused execution.

subgraph Incumbent["The Incumbent Fortress (Microsoft)"] A["OpenAI IP Partnership"] B["GitHub Ecosystem"] C["VS Code Dominant IDE"] end

subgraph Insurgent["The Agile Insurgent (Cursor)"] D["Zero Legacy Codebases"] E["Hyper-Focused Harness"] F["Pure Execution Velocity"] end

Incumbent -->|"Defensive coordination overhead"| G["Slower Iteration Cycles"] Insurgent -->|"Leverages external frontier models"| H["Disruptive Market Win"] ```

Lungren maps the Cursor lesson directly onto medicine. The entire academic medical enterprise—its curricula, tenured faculties, clinical trials, and multi-year peer-review processes—was constructed around the premise that human expertise is an exceptionally scarce commodity. Today, by the time an academic paper clears peer review and reaches print, the underlying models have been superseded. Attempting to "pour intelligence" over legacy, ossified healthcare workflows is futile; insurgent care-delivery models must instead be built fresh alongside existing institutions.

- **The Cursor Precedent**: A lean team outcompeted Microsoft despite the incumbent holding OpenAI licensing, GitHub, and the market-leading IDE. - **The Speed Mismatch**: Academic peer review spans months or years, while foundational AI models iterate on a cycle of weeks, rendering conventional validation frameworks obsolete upon publication.

---

[19:30](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1170s) The Ancien Régime of Granite and the Collapse of Expertise Scarcity

Eric Larsen embraces Lungren’s assessment, acknowledging that AI is the most exponential technology in human history. The acceleration is so extreme that Larsen admits to repudiating sections of his own *Healthcare's Oppenheimer Moment* essay just months after its June 15 release, abandoning plans for minor revisions in favor of drafting a completely new manuscript. In his view, healthcare represents the ultimate "ossified establishment"—a civilization-scale *ancien régime* symbolized by century-old institutions like the American Medical Association (AMA), the American Hospital Association (AHA), the Mayo Clinic, and the Cleveland Clinic, housed in monolithic granite buildings with Latin inscriptions carved into stone.

```mermaid flowchart LR accTitle: The Demonetization of Physical Healthcare Delivery accDescr: Flowchart tracing how collapsing cognitive costs threaten the real-estate-heavy hospital model.

A["Medical Expertise as Scarce Asset"] --> B["Geographic Co-location\n($1T Hospital Real Estate)"] B --> C["Aggregated Subspecialists\n(Cardio, GI, Neuro)"]

D["Frontier AI Compute"] -->|"Asymptotic cost decline"| E["Abundant, Free Cognition"] E -->|"Disintermediates"| B E -->|"Decentralizes care away from"| C ```

In a Darwinian environment defined by exponential velocity, century-old survival is an "unnatural act." When medical expertise ceases to be a scarce commodity and its price falls asymptotically toward the raw cost of compute, the economic justification for the modern hospital collapses:

- **Capital Footprint at Risk**: The U.S. hospital sector generates $1.7 trillion in revenue and sits on more than $1 trillion in physical real estate. - **The Co-Location Fallacy**: Sprawling, centralized hospital campuses were built solely because human cognitive specialization required physical proximity—forcing gastroenterologists, cardiometabolic experts, and neurologists under one roof to manage clinical complexity. - **The Impending Disintermediation**: As clinical cognition decouples from physical geography and human limits, the centralized arbitration model championed by traditional health systems faces structural obsolescence.

[22:58](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1378s) Cognitive Abundance and the Collapse of Medical Bureaucracy

Human biology imposes a severe physical limit on medical practice: physicians look at the human body "through a straw" because biological brains can only encompass a finite amount of information. Eric Larsen illustrates this through the accelerating pace of medical knowledge: in 1950, it took an estimated 50 years for the sum total of human medical knowledge to double, whereas by 2019, that doubling window had collapsed to just 73 days. Confronted with massive cognitive overload, medicine reacted by drawing progressively smaller circles around what any individual knows, creating hyper-subspecialization where "experts know more and more about less and less." Society then erected a multi-trillion-dollar bureaucratic complex solely to aggregate and coordinate these fragmented specialists under one roof.

Large language models (LLMs) fundamentally challenge this architectural necessity by shifting cognitive scarcity into cognitive abundance. While traditional corporations exist to coordinate individual specialists, LLMs "democratize expertise" and "arm the rebels," turning the individual patient or clinician into an agile polymath. Larsen notes that with personal superintelligence, a single person can operate simultaneously like a doctor, a lawyer, and a consultant. While the frontier of capability remains jagged—world-class mathematicians like Terence Tao are not instantly disintermediated, even as longstanding Erdős problems are systematically falling—the broader economic implications are staggering. The United States spends $6 trillion, or nearly 18% of its GDP, on an inequitable healthcare system that functions well primarily for the wealthy, white, and urban. Once cognitive medical expertise becomes free and broadly accessible, the sprawling edifices built to meter out that scarcity can no longer survive in their historical form.

- **Knowledge Doubling Rate:** From 50 years in 1950 to an estimated 73 days by 2019. - **U.S. Healthcare Scale:** Consumes approximately 18% of national GDP ($6 trillion annually). - **Core Structural Dynamic:** Legacy medical institutions were designed to arbitrate and ration cognitive scarcity; generative AI flips this condition into radical abundance.

---

[25:23](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1523s) Incumbents, Insurgents, and the Stargate Moment

Justin Norden pushes on whether incumbent health systems can successfully execute this transition or whether unencumbered insurgents will displace them, pointing to the software battle between Cursor and Microsoft as an analogy. Larsen agrees, tracing Microsoft's vulnerability back to January 2025 at Davos. While Satya Nadella was being interviewed about Microsoft's capital expenditures and casually stating he was "good for my $80 billion," Sam Altman, Larry Ellison, and Masayoshi Son were sitting in the Roosevelt Room at the White House announcing the massive Stargate supercomputing initiative. In Larsen's view, Microsoft forfeited its decisive lead in that single moment, paving the way for hyper-focused, insurgent coding environments like Cursor (now backed by Elon Musk) to challenge the legacy empire.

```mermaid flowchart TD accTitle: Incumbent vs Insurgent Adaptation Paths accDescr: Diagram contrasting how incumbent legacy organizations and unencumbered AI-native insurgents approach healthcare transformation.

subgraph Incumbent["Legacy Incumbents"] I1["Massive Capital & System of Record"] --> I2["Heavy Regulation & Change Friction"] I2 --> I3["Gradual Stratification Across 150 CEOs"] end

subgraph Insurgent["AI-Native Insurgents"] S1["First-Principles Architecture"] --> S2["Zero Legacy Overhead & Agentic Workflows"] S2 --> S3["Rapid Global Deployment (e.g., Tsinghua AI Hospital)"] end

I3 -.->|"Must adapt or get leapfrogged"| S3 ```

Applying that lesson to healthcare reveals both unique barriers and existential threats. Healthcare is notoriously litigious, hyper-regulated, and incrementalist—a reality dictated by the fact that if systems move recklessly, "people die." While that friction gives healthcare incumbents a temporary head start, incumbency is merely an operational runway rather than an invariant law of nature. The true competitive threat may not even emerge from domestic competitors, but from greenfield, authoritarian regimes unencumbered by Western legacy structures, such as Saudi Arabia or China, where Tsinghua University launched an autonomous AI hospital. A narrow oligopoly of roughly 150 health system CEOs currently wields deterministic power over the pace of domestic adoption, producing a distinct stratification between aggressive pioneers building parallel AI-native tracks and sluggish peers waiting on the sidelines.

- **Davos / White House Contrast (Jan 2025):** Nadella committed to an $80 billion CapEx while Altman, Ellison, and Son unveiled the multi-hundred-billion-dollar Stargate initiative in the Roosevelt Room. - **The Nature of Incumbency:** Regulatory moats provide time, but do not protect institutions that refuse to self-disrupt. - **Global Greenfield Experiments:** Initiatives like Tsinghua University's AI hospital demonstrate what is possible when healthcare delivery is architected from first principles.

---

[29:22](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1762s) The Headless EHR and Agentic System of Record

Matt Lungren proposes an alternative intermediate path for incumbent survival, drawing a comparison to recent enterprise shifts seen with Salesforce. Rather than attempting to maintain rigid human-facing interfaces, forward-looking software giants are transitioning to "headless" architectures. Under this model, an enterprise system recognizes that future users will rarely be human operators clicking through graphical menus; instead, software will be operated almost exclusively by autonomous AI agents collaborating with one another.

```mermaid flowchart LR accTitle: Evolution of Healthcare EHR Interaction accDescr: Flow diagram showing the transition from human UI interaction to headless agentic interaction with the healthcare system of record.

subgraph LegacyModel["Legacy Human Workflow"] A["Clinician / Staff"] -->|"Manual clicks & documentation"| B["Monolithic EHR UI"] B --> C["Database / System of Record"] end

subgraph AgenticModel["Headless Agentic Workflow"] D["AI Medical Agents"] -->|"Autonomous API Actions"| E["Headless System of Record (Epic / Oracle)"] F["Software Subsystems"] -->|"Agent-to-Agent Coordination"| E end ```

Lungren frames the existential choice facing major electronic health record (EHR) vendors such as Epic and Oracle: will they cling to software designed around human clicks, or will they open their gates to the "barbarians" and restructure their tech stacks to serve autonomous agents? If an incumbent EHR can successfully pivot to become the reliable, headless system of record for agent-to-agent transactions, it can ride the exponential curve while preserving its structural moat. Even though the regulatory and compliance hurdles of autonomous medical software are daunting, regulators themselves are actively initiating dialogues with startups and insurgents rather than relying solely on traditional legacy incumbents.

- **The Headless Transformation:** Shifting the core customer profile from human clinicians manually clicking interface buttons to autonomous agents executing programmatic tasks. - **Agent-to-Agent Architecture:** Anticipating a workflow ecosystem where healthcare intelligence operations are negotiated directly between autonomous models and core databases. - **Evolving Regulatory Dynamics:** Agencies are breaking standard protocol by actively seeking input from AI insurgent developers alongside established legacy vendors.

---

[31:21](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1881s) The Implementation Overhang: You Don't Need Another Breakthrough

Justin Norden challenges Eric Larsen's assertion that the AI exponential must keep accelerating for these deep structural shifts to materialize. Norden argues forcefully that the healthcare industry is suffering from a massive implementation overhang: even if frontier AI model development froze entirely today, society already possesses more than enough raw technological capability to fuel a decade of radical, fundamental transformation across clinical workflows.

Leading technology organizations like OpenAI, Anthropic, and Cursor are already operating orders of magnitude ahead of the median healthcare enterprise simply by aggressively leveraging existing, off-the-shelf tools. Norden warns healthcare leaders against complacency and the tempting excuse of waiting for models to reach perfect reliability before taking action. The real barrier to progress is no longer a deficit in underlying machine intelligence, but the operational inertia of legacy institutions that remain drastically behind what contemporary models can already execute.

- **Ten-Year Implementation Overhang:** Current models provide enough cognitive runway to fundamentally alter clinical delivery without requiring any new foundational breakthroughs. - **Frontier Lab Divergence:** Elite software engineering teams already demonstrate productivity gains orders of magnitude higher than healthcare organizations using identical model architectures. - **The Wait-and-See Trap:** Executive hesitation rooted in waiting for future model checkpoints simply widens the operational gap between incumbents and the technological frontier.

---

[33:00](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1980s) Bending the Cost Curve and Baumol's Cost Disease

Norden pivots the discussion toward macroeconomic healthcare expenditures and asks whether technology has already begun to bend the cost curve. Larsen enthusiastically highlights a Harvard preprint paper by David Cutler and Klarnet that thoroughly disrupted his view on the sector's financial trajectory. Larsen recounts how he was previously villainized and made unpopular among industry insiders for arguing publicly that the United States could shave 500 to 700 basis points off healthcare's share of national GDP over the next few years.

The resistance stems from healthcare's massive economic footprint as an employment engine. Out of the $6 trillion spent annually, $3.2 trillion represents direct labor costs, employing 23.8 million individuals—equivalent to one out of every six working adults in the United States. Healthcare has historically represented the quintessential victim of Baumol's cost disease: while manufacturing, industrial production, and hospitality achieved dramatic productivity gains through automation and efficiency, healthcare wages continued to rise without corresponding productivity breakthroughs, driving total expenditures inexorably upward.

- **Harvard Paper Reference:** Work by David Cutler and Klarnet analyzing U.S. healthcare spending trajectories. - **The Larsen Hypothesis:** A projected potential reduction of 500 to 700 basis points in healthcare's total share of U.S. GDP. - **Healthcare Labor Statistics:** - Annual sector expenditure: $6 trillion. - Total labor component: $3.2 trillion. - Workforce size: 23.8 million people (1 in 6 working American adults). - **Baumol's Cost Disease:** Stagnant clinical productivity paired with rising wages has historically driven runaway expenditure growth across the entire medical sector.

[34:19](https://www.youtube.com/watch?v=pUF0o57YdL8&t=2059s) Demonetizing Cognition and the Trillion-Dollar Discrepancy

Continuing the discussion on Baumol’s cost disease—where healthcare must constantly raise wages to compete for talent without gaining the typical productivity dividends, driving prices ever upward—Eric Larsen explains how artificial intelligence fundamentally breaks that dynamic. He frames AI as the "industrialization of intelligence." Just as the medical industry unlocked massive savings by transitioning from branded pharmaceuticals to generics, or migrating procedures from inpatient hospital beds to outpatient facilities, AI takes an asset that has historically been scarce—cognition—and makes it abundant. In economic terms, when a scarce resource becomes abundant, it gets demonetized and collapses in price. While Eric previously treated the prospect of shaving 500 to 700 basis points off healthcare spending as an intuitive thesis, a recent landmark economic paper revealed that the healthcare cost curve has, surprisingly, already begun to bend.

In 2010, actuaries at the Centers for Medicare & Medicaid Services (CMS) incorporated the projected effects of the Affordable Care Act (ACA) and forecasted that by 2024, healthcare spending would consume 21.2% of United States GDP, totaling roughly $6.3 trillion. The actual results defied expectations: healthcare landed at 18.0% of GDP and $5.3 trillion. That represents a 320-basis-point drop and a $977 billion shortfall from what was projected—nearly a trillion dollars in unexpected savings in 2024 alone. Looking across the entire 14-year window from 2010 to 2024, the cumulative savings reached a staggering $6.7 trillion compared to actuarial models. Larsen highlights that never once in any 14-year stretch since the federal government started tracking national health expenditure data in 1960 has such a dramatic downward divergence occurred, demonstrating that the US is actively inflecting its cost curve relative to other OECD nations.

```mermaid flowchart TD accTitle: Historic Pre-AI Cost Reductions to Future AI Deflation accDescr: Flowchart illustrating how historical structural savings levers compare to AI demonetizing scarce cognition.

subgraph HISTORIC["2010–2024 Pre-AI Cost Reductions ($6.7T Saved)"] direction TB A["Site-of-Care Shifts<br/>(e.g., Inpatient to Outpatient)"] B["Payer Controls<br/>(Prior Authorizations & Clawbacks)"] C["Healthier Population & Tech<br/>(~14% Tech Contribution)"] end

subgraph ANALOGY["The Deflationary Mechanism"] direction TB D["Branded Drugs to Generics"] E["Scarce Cognition to Abundant AI"] end

HISTORIC --> ANALOGY ANALOGY --> F["Demonetized Healthcare Costs<br/>& Bending the Cost Curve"] ```

- **Projected vs. Actual 2024 Spending**: CMS predicted 21.2% of GDP ($6.3 trillion); actual spending came in at 18.0% of GDP ($5.3 trillion), representing a $977 billion reduction. - **Cumulative 14-Year Dividend**: Between 2010 and 2024, cumulative healthcare expenditures were $6.7 trillion lower than the post-ACA actuarial baseline. - **Factor Decomposition**: The paper’s authors attribute roughly 14% of the curve bending directly to technology, with the remainder driven by site-of-care shifts, payer prior-authorization crackdowns, clawbacks, and general population health dynamics—all achieved before modern generative AI was even deployed.

---

[37:03](https://www.youtube.com/watch?v=pUF0o57YdL8&t=2223s) Site-of-Care Shifts, GLP-1 Deflation, and Untapped Alpha

Because this massive inflection occurred entirely in a pre-AI world, Larsen argues that it serves as an empirical, proven roadmap for how targeted interventions can bend the cost curve further. While new medical innovations are notoriously inflationary upon arrival—often because they treat high-cost conditions that were previously unaddressed, much like coronary artery bypass graft (CABG) surgery did initially—they eventually become powerful deflationary forces. Larsen points to the migration of total hip and total knee arthroplasty as the gold standard of structural savings: moving joint replacements from inpatient hospital rooms to ambulatory and outpatient surgical suites accounted for $94 billion of the $977 billion total savings in 2024 alone.

He applies this exact lifecycle to GLP-1 receptor agonists. Although GLP-1s are viewed today as budget-busting and inflationary, they will inevitably become deeply deflationary as costs normalize and downstream complications are averted. Larsen shares real-world evidence from digital health company eMed, where he sits on the board: they are preparing to publish data showing that against a backdrop of 10% general medical inflation, employers with workforces adherent to GLP-1 regimens experienced an absolute 5% reduction in their total healthcare costs. When paired with the structural shift from scarce clinical cognition to ubiquitous automated reasoning, these clinical and site-of-care precedents demonstrate how rapidly medical overhead can be hollowed out.

- **Joint Replacement Migration**: Transitioning total hip and total knee surgeries out of inpatient settings saved Medicare and payers $94 billion in 2024. - **eMed GLP-1 Case Study**: Employees adherent to GLP-1 therapies saw a 5% decline in total healthcare spend despite an underlying 10% medical inflation environment. - **Cognitive Abundance**: Shifting from expensive, scarce cognitive labor to abundant automated reasoning mirrors the historic margin deflation seen when blockbusters transitioned to generic drugs.

---

[38:25](https://www.youtube.com/watch?v=pUF0o57YdL8&t=2305s) An 84-Page Roadmap and Optimism for the Future

Larsen urges listeners to digest the findings themselves, noting that while the 84-page paper is dense and technically demanding, its implications are monumental: "Throw it into Claude, throw it into GPT-5, 6, or just read the damn thing, because it is a seminal paper." Expressing disbelief that the study has not received wider mainstream distribution, he takes a playful, barbed swipe at conventional economists: "Look, if Daron Acemoglu can get a Nobel Prize for basically saying dumb stuff, like AI is not going to affect productivity, I'm going to nominate these two for an economics Nobel Prize."

The hosts reflect on the broader significance of the discussion, marveling at how much untapped "alpha" remains in healthcare before frontier AI models even enter full clinical deployment. Matt and Justin observe that the substantial cost curve inflection documented between 2010 and 2024 came from blunt-instrument policy shifts and older pharmacological breakthroughs—noting that GLP-1s are essentially a two-to-three-decade-old class of molecules. If legacy operational maneuvers and older pharmacological tools could silently bend the healthcare cost curve by trillions of dollars, the addition of autonomous intelligence and demonetized cognitive labor offers profound reason for optimism. Rather than facing an inevitable exponential explosion in national health expenditures, the system may already be on a viable trajectory toward mitigating entrenched economic and structural inequities.

## Notable quotes > [04:17](https://www.youtube.com/watch?v=pUF0o57YdL8&t=257s) Get ready. You are not the apex predator. — Eric Larsen

> [11:45](https://www.youtube.com/watch?v=pUF0o57YdL8&t=705s) I don't know. I'm thinking about the patient. — Dario Amodei

> [22:58](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1378s) experts know more and more about less and less — Eric Larsen

> [25:23](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1523s) good for my $80 billion — Satya Nadella

> [25:23](https://www.youtube.com/watch?v=pUF0o57YdL8&t=1523s) people die — Eric Larsen

> [34:19](https://www.youtube.com/watch?v=pUF0o57YdL8&t=2059s) industrialization of intelligence — Eric Larsen

> [38:25](https://www.youtube.com/watch?v=pUF0o57YdL8&t=2305s) Throw it into Claude, throw it into GPT-5, 6, or just read the damn thing, because it is a seminal paper. — Eric Larsen

> [38:25](https://www.youtube.com/watch?v=pUF0o57YdL8&t=2305s) Look, if Daron Acemoglu can get a Nobel Prize for basically saying dumb stuff, like AI is not going to affect productivity, I'm going to nominate these two for an economics Nobel Prize. — Eric Larsen

## Mentioned Affordable Care Act, American Hospital Association, American Medical Association, Anthropic, Bob Wachter, Centers for Medicare & Medicaid Services, Claude, Cleveland Clinic, Curai Health, Cursor, Dario Amodei, Daron Acemoglu, David Cutler, Deep Blue, Dr. Algorithm: The 20% Doctor, Elting Morison, Elon Musk, eMed, Epic, Erik Brynjolfsson, Ezekiel Emanuel, Garry Kasparov, GitHub, GPT-5, Justin Norden, Klarnet, Larry Ellison, Masayoshi Son, Matt Lungren, Mayo Clinic, Men, Machines, and Modern Times, Microsoft, Neal Khosla, OpenAI, Oracle, Qualified Health, Ray Kurzweil, Salesforce, Sam Altman, Satya Nadella, SignalFire, Stargate, Terence Tao, The Advisory Board Company, Thrive Capital, TowerBrook Advisors, Tsinghua University, Vinod Khosla, Visual Studio Code

## Video description Learn more about Stanford's online Healthcare AI programs: https://stanford.io/3NEt7uE Check out the AI in Healthcare series playlist:https://stanford.io/3NEt7uE

Matt Lungren, Stanford University - https://profiles.stanford.edu/matthew-lungren Justin Norden, Stanford University - https://profiles.stanford.edu/justin-norden

Guest speaker: Eric Larsen, President, TowerBrook Advisors; venture partner, Thrive Capital and SignalFire

In this episode of the Stanford Healthcare AI Podcast, Justin and Matt sit down with Eric Larsen, President at TowerBrook Advisors and venture partner at Thrive Capital and SignalFire, to explore whether AI has already begun to bend the U.S. healthcare cost curve, and why this may be healthcare’s Oppenheimer moment. They unpack a controversial paper on autonomous AI exceeding physicians, debate how far and how fast AI will displace “prestige professions,” and discuss GLP‑1s, site‑of‑care shifts, and a cost-curve paper that suggests nearly $1T in unexpected savings. They ask: What happens when medical expertise becomes abundant and can incumbent health systems adapt in time?

[Source](https://www.youtube.com/watch?v=pUF0o57YdL8)

中文简报

医疗AI系列:我们是否已经扭转了医疗成本曲线? 专家小组探讨了一个发人深省的论点:自主式 AI 正开始超越医生,并类比了竞技国际象棋中人机协作最终反而降低纯算法准确率的现象。Eric Larsen 认为,AI 将使临床专业技能从人为制造的稀缺商品转变为充裕资源,从而威胁到传统医院地产和医疗行业公会数万亿美元的经济模式。主持人强调了 Cursor 等新兴颠覆性工具相较于传统老牌机构的灵活性,探讨了无头 EHR 架构,并着重指出当前模型已存在长达十年的落地实施滞后。最后,讨论分析了相关经济数据,表明甚至在部署 AI 之前,美国医疗支出就比 2010 年的预测值低了近 1 万亿美元;这表明将历史上的就医地点先例、GLP-1 疗法与认知充裕相结合,可能会带来前所未有的通缩效应。 Cutler 和 Klarnet 的经济分析显示,2024 年美国医疗支出占 GDP 的比例为 18.0%(5.3 万亿美元),低于 CMS 在 2010 年预测的 21.2%(6.3 万亿美元),2024 年意外节省了 9770 亿美元,并在 14 年间累计节省达 6.7 万亿美元。 (34:19) 美国医疗系统在 2380 万名员工身上投入了 3.2 万亿美元的人力成本,但随着自主式 AI 将专业技能的边际成本推向趋近于零,临床认知能力的工业化正对高达 50% 的初级医疗岗位构成威胁。 (11:45) 随着生成式 AI 将临床推理与地理集中解耦,消除了集中式专科设施最初的经济合理性基础,价值超过 1 万亿美元的医院实体资产正面临结构性淘汰。 (19:30) 医疗行业正面临长达十年的落地实施滞后:现有的基础模型已具备充足的认知能力来推动彻底的工作流程变革,无需等待未来的算法突破。 (31:21)

Reading summary

Healthcare investors and clinicians argue that autonomous artificial intelligence will systematically dismantle the economic scarcity of medical cognition, building on pre-existing structural shifts that have already begun bending the U.S. healthcare cost curve. Autonomous AI Benchmarks and the Doorman Problem (1:28) A polarizing opinion paper by Ezekiel Emanuel, Neal Khosla, and Vinod Khosla claims autonomous AI now exceeds human clinicians across multiple benchmarked tasks, even asserting that pairing AI with physicians yields worse results than autonomous deployment. Matt Lungren notes that while benchmark outperformance is real, it runs into what Bob Wachter termed 'the Doorman Problem': high accuracy on narrow benchmarks—such as pneumonia detection—addresses only a tiny fraction of a physician's daily physical, interpersonal, and cognitive micro-tasks. Eric Larsen defends the paper's core thesis by drawing an analogy to competitive chess. Following Garry Kasparov's 1997 loss to Deep Blue, human-machine 'centaur' teams initially outperformed pure engines between 2005 and 2012, but post-2012 engines reached a level where human intervention actively degraded machine performance. Larsen asserts that across five cognitive domains, AI matches or exceeds human fidelity to ground truth, challenging the historic scarcity that underpins high-prestige medical specialties. Incumbent EHR Fragility and the Insurgent Advantage (17:01) The panel questions whether incumbent healthcare giants can adapt to exponential AI velocity. Lungren points to the coding tool Cursor, which outmaneuvered Microsoft despite Microsoft holding OpenAI intellectual property, GitHub, and the market-leading IDE. Lungren argues that academic medicine's multi-year peer review and clinical curricula cannot keep pace with model update cycles measured in weeks, making it difficult to simply graft new AI capabilities onto legacy operational workflows. To survive disintermediation, Lungren suggests major electronic health record (EHR) vendors like Epic and Oracle must evolve into 'headless' systems of record. In this framework, software shifts away from clinician-facing graphical user interfaces toward programmatic architectures designed for autonomous AI agents coordinating directly via APIs. Larsen warns that if domestic incumbents resist, unencumbered greenfield initiatives—such as Tsinghua University's autonomous AI hospital—could leapfrog Western institutions. Implementation Overhang and Professional Guild Resistance (11:45) Larsen argues that legacy medical associations are responding to autonomous AI through the classic four-stage cycle identified by MIT historian Elting Morison: initial denial, pedantic rational rebuttals over study citations, ad hominem attacks on champions, and eventually forced adaptation. The defensive reaction reflects economic anxiety: out of $6 trillion in annual U.S. healthcare spending, $3.2 trillion represents direct labor covering 23.8 million workers, facing potential 50% entry-level dislocation. Justin Norden pushes back against the belief that continued frontier model acceleration is strictly required to reshape healthcare. He asserts the industry is experiencing a massive 'implementation overhang,' meaning that existing, off-the-shelf model architectures already provide sufficient capability to fuel a decade of radical workflow reorganization if institutions can overcome bureaucratic inertia and adoption delays. Demonetizing Scarce Cognition to Bend Healthcare Costs (34:19) Healthcare has historically suffered from Baumol's cost disease, where rising wages without corresponding productivity gains drive up spending. Larsen highlights a Harvard working paper by David Cutler and Klarnet demonstrating that the U.S. cost curve has, unexpectedly, already begun to inflect before widespread AI integration. In 2010, CMS actuaries projected healthcare spending would reach 21.2% of GDP ($6.3 trillion) by 2024; actual spending was 18.0% ($5.3 trillion)—a $977 billion divergence in 2024 alone and a cumulative $6.7 trillion reduction over 14 years. Cutler and Klarnet attributed roughly 14% of those historical gains to technology, with the rest driven by payer controls and site-of-care migrations—such as shifting joint replacements to outpatient surgical suites, which saved $94 billion in 2024. Larsen argues that transitioning from scarce human labor to abundant AI cognition will mimic the deflationary margin collapse seen when branded pharmaceuticals transition to generics, reinforced by emerging clinical therapies like GLP-1s, which digital health company eMed found drove an absolute 5% drop in total workforce healthcare spend. The hosts conclude that because blunt operational shifts and pre-AI technologies silently removed trillions in projected spending, adding autonomous intelligence creates genuine room for optimism. However, whether health systems realize these macroeconomic dividends depends on whether entrenched leadership can adopt headless, agentic models before non-traditional insurgents capture delivery.

Source quotes

[4:17] Eric Larsen: Get ready. You are not the apex predator. [11:45] Dario Amodei: I don't know. I'm thinking about the patient. [22:58] Eric Larsen: experts know more and more about less and less [25:23] Satya Nadella: good for my $80 billion [25:23] Eric Larsen: people die [34:19] Eric Larsen: industrialization of intelligence [38:25] Eric Larsen: Throw it into Claude, throw it into GPT-5, 6, or just read the damn thing, because it is a seminal paper. [38:25] Eric Larsen: Look, if Daron Acemoglu can get a Nobel Prize for basically saying dumb stuff, like AI is not going to affect productivity, I'm going to nominate these two for an economics Nobel Prize.

Original transcript

[0:12] Welcome back to the Stanford Health Care AI podcast. [0:15] We are thrilled to be joined by friend Eric Larsen, who [0:19] is president at TowerBrook Advisors, venture [0:23] partner at Thrive Capital, venture partner at SignalFire. [0:27] He is an investor in asset qualified health as well. [0:31] And really just a health care visionary working for 25 years, [0:35] being president of the advisory board, [0:37] and being known by many as whisperer [0:39] to what is coming next in health care. [0:41] So welcome, Eric. [0:42] Justin, it's an honor to be here with you and Matt. [0:45] I obviously think the world of you both. [0:47] And I'm a proud investor and qualified rocketship, [0:50] you guys are doing amazing stuff. [0:52] So honored to be part of the pod. [0:55] Appreciate it. [0:57] Well, there are way too many topics to discuss. [0:59] And even as our just pre-conversation recording live, [1:03] there's too much to go on. [1:05] But we have to start with maybe the most publicized recent paper [1:11] on autonomous AI exceeding physicians [1:16] that Zeke Emanuel, Neal Khosla, Vinod Khosla [1:20] wrote just a few weeks back. [1:22] I'll pull up the headline here. [1:24] But Matt, as the practicing physician [1:26] amongst the three of us, well, what's your take? [1:28] Let's get us started. [1:30] OK. [1:31] So just for the audience, unless you're under a rock, [1:33] you've definitely heard about this paper. [1:35] You've at least had a take on it. [1:36] And this is just the culmination of some, I would say, [1:40] maybe cherry-picked to be slightly provocative, [1:43] but in terms of the evidence that they brought [1:45] to bear for this largely opinion piece, [1:48] but grounded in some reality. [1:49] And I think we've seen some of these trends. [1:51] We've talked about some of them. [1:52] And they include things like when [1:54] you have these AI versus physician papers. [1:58] And then you do AI plus physician, [2:00] and you look at these different tasks [2:01] that they ask folks to do in these academic papers. [2:05] We keep finding that AI plus physician is actually [2:09] worse than just the AI alone, which often beats physicians. [2:13] But the conclusion that they're taking this logically towards [2:16] is, should we just let AI autonomously deliver care? [2:22] And which, again, very provocative. [2:25] It's caused tons of hot takes and reactions. [2:27] I think of all the different reactions I've read, [2:30] I align probably closest with Bob Walker's response. [2:34] And he wrote a really nice Substack on this. [2:36] And he called it the Doorman Problem. [2:37] But the point is that if you narrow things down to a task, [2:41] and this has happened to us in radiology since the beginning, [2:44] it can beat me on looking for pneumonia. [2:46] That's 1% of what I do. [2:48] And I think it's the comprehensive collection [2:50] of tasks that we're still not putting our finger on in terms [2:54] of a benchmark. [2:56] But the better question, I think, to ask is not, [2:58] do we just throw AI out there and have [3:00] it take care of all patients? [3:01] It's more, how do we need to reinvent [3:04] the practice of medicine so that we get the benefits of what this [3:08] can deliver in terms of access to care, better [3:10] knowledge, better prescriptions, better eye [3:14] care, surgical decisions, whatever those things are, [3:17] but then also allow us to cover the rest of the task that we do? [3:21] And I would also argue that when you follow someone around, [3:26] I think, Graham had a really nice talk about this, [3:30] if you follow someone around in a given day, [3:33] within five minutes in a clinic, you're going to be like, [3:35] oh, wait, we're going to need a lot more advancements, [3:38] a lot more capability to do the 19 things I just saw you [3:42] do in the last five minutes. [3:43] And so it's a balance to me and I don't know the answer. [3:46] We've been talking a lot about administrative tasks [3:48] being the place to really focus and freeing up physicians, [3:52] but I'm not sure that's necessarily [3:54] the right approach either. [3:56] So I'm curious to hear what you guys think. [3:58] But to me, it's like, yes, I would [4:00] argue that any benchmark you can create, you can hill climb [4:03] and you can certainly beat humans on. [4:05] The question is, are these benchmarks reflective of reality [4:09] to the extent that they need to draw these conclusions? [4:11] And I just don't know yet. [4:13] I'm just not convinced yet on the benchmarks. [4:17] Well, maybe Justin, I'll pile on. [4:21] I'm not a clinician, so I proceed with a ton of humility [4:25] here on the topic. [4:27] But this article, this opinion piece really resonated with me. [4:32] And obviously, we think the world [4:35] of Vinod and Neal and Zeke, we do a lot with them. [4:39] I will say that Vinod has been probably the most clairvoyant [4:43] technologist for the last 75 years, [4:46] maybe with the exception of Ray Kurzweil, [4:48] in terms of him being super vindicated in his predictions. [4:53] And in, I think, it was 2016, he wrote Dr. Algorithm [4:56] or the 20% Doctor. [5:00] And that was a really inflammatory piece, [5:04] even though, I think, it's going to prove [5:06] to be totally prophetic. [5:09] But everybody rose up in arms. [5:11] And I've noticed Vinod, over the last few years, [5:14] get a lot more diplomatic and calibrated. [5:19] The Dr. Algorithm was pretty incendiary, [5:22] pretty flame-throwing. [5:24] Now, I think this is a really measured piece that [5:29] is a meta-analysis of a lot of other industries too, [5:33] basically suggesting that in these five cognitive domains [5:38] for a clinician, the AI is demonstrably superior and more [5:43] accurate and has more fidelity to ground truth. [5:46] But the bigger intuition is that it's this Garry Kasparov, 1997, [5:52] Deep Blue getting defeated. [5:54] And that was this big epistemic shock wave. [5:59] And then you had this period-- [6:03] I think the last time a human beat [6:07] one of the real premier chess models was in, [6:10] whatever, the mid-2000s. [6:13] Then you had this period from 2005 [6:15] to 2012, where this centaur idea, and Garry Kasparov [6:19] actually wrote a book about human machine optimization. [6:23] And from 2005 to 2012, human plus machine was ascendant. [6:28] But then after 2012, the machines beat everybody. [6:32] And what Vinod and Neal and Zeke are saying in this [6:34] is that superimposing human judgment [6:38] on top of a functionally-verifiable domain [6:42] actually degrades the accuracy of the AI. [6:45] And everybody's freaking out, and they're [6:48] finding all sorts of methodological flaws [6:50] in this study. [6:51] And Matt, your commentary on it is super [6:54] principled and measured. [6:55] But a lot of the online stuff has been pretty ad hominem [7:01] and [AUDIO OUT] stuff. [7:03] And I think there's a real meta-intuition in this, which [7:08] I subscribe to, which is if you look [7:10] at the trajectory of the cognitive ability of the AI [7:14] and every epistemic domain, starting with areas [7:17] of functional verifiability, then going to codified ability, [7:20] then things you can decontextualize, [7:22] one of our refuges used to be tribal knowledge [7:25] or embodied knowledge or tacit knowledge. [7:29] But it turns out, Erik Brynjolfsson [7:30] just wrote this amazing study, your colleague at Stanford, [7:35] that a lot of the tacit knowledge [7:38] is now discoverable or learnable. [7:41] He uses autonomous driving as an example. [7:44] So I guess where I land is, go ahead and find [7:47] methodological flaws in this perspective piece. [7:50] Go ahead and rage against the dying of the light. [7:54] But the fact is, I think we're going [7:56] to see the prestige professions systematically dislocated [8:03] by this ever increasing synthetic Jupiter brain. [8:07] And the implications for medicine [8:09] are huge because our entire organization of our $6 trillion [8:14] industry has been predicated on scarcity, [8:17] scarcity of cognition, scarcity of it [8:21] takes 12 years to train radiologists. [8:23] And therefore, there's no elasticities of supply. [8:26] I think what Vinod and Zeke and Neal are pointing to is [8:30] that humanity get ready. [8:32] You are not the apex predator. [8:34] And I think the implications for medicine are very good, [8:38] if we can store this transition and compensate these [8:45] self-sacrificial physicians who spent 12 years of their life [8:48] and incurred $250,000 in academic debt. [8:52] So anyway, that's my take on this. [8:54] I love the piece. [8:55] I thought it was really profound. [8:57] Well, just really quick to react to that, before, [8:59] Justin, you jump in. [9:00] I will say, I think that what I'm talking about [9:03] is we're falling into this-- we're talking about one [9:06] thing in an exponential. [9:08] And any discussion around an exponential to me is hard. [9:12] And I think you're much more looking at, OK, [9:15] the slope is much more important than the snapshot on the ground. [9:18] And again, I was talking to somebody about this yesterday, [9:23] I'm a little worried we're not thinking delusional enough. [9:25] Even this piece, to me, isn't delusional. [9:28] And the reason I say that, it feels to me-- [9:31] I did public health degree. [9:32] And one of the things we learned about exponential spread, [9:35] the COVID thing is such a beautiful example, in some ways, [9:37] it feels like we're in that stage [9:39] where-- remember when we were like, hey, [9:41] if we don't let that cruise ship of COVID people dock, [9:44] we'll stop COVID from spreading in the US. [9:46] So let's not let them dock or let's ground some flights. [9:49] But we already knew the exponential, [9:53] it was already gone. [9:54] We had already lost them. [9:55] The are not. [9:57] Right. [9:57] So to me, I feel like we're having some of these debates. [10:00] And again, they're useful to have [10:03] in every corner of medicine. [10:04] But at the same time, it's the slope that I'm missing. [10:08] And you're looking at that and saying, guys, [10:12] it's already decided almost. [10:15] So we have to start reorganizing society, [10:19] how we think about every institution. [10:22] But certainly, health care is right [10:23] smack in the center of that because it's tomorrow, [10:27] then the next day, then the next day. [10:28] We're progressing at a rate that the current discussion [10:32] isn't going to capture. [10:33] You're saying something really important, [10:35] Justin, sorry, Matt and I are monologuing. [10:37] I'm going to say something really quickly and then shut up. [10:40] Elting Morison, who was this MIT luminary professor, [10:47] wrote this amazing piece in 1955 called Men, Machines, [10:50] and Modern Times. [10:51] So a little anachronistic in the title, but Men, Machines, [10:55] and Modern Times. [10:56] And what he said was that when a society is confronted [11:01] with the new radical technology, it [11:03] reacts in a pretty predictable, formulaic way. [11:05] First, it ignores it, then it seeks to rationally rebut it. [11:11] If that fails, it mocks it and uses ad hominems [11:15] to make fun of the champions. [11:17] And then only when a leader of sufficient moral authority [11:20] and energy comes in and rides in over the top [11:24] does the adaptation happen. [11:26] And I think you're going to see this with law, consulting, [11:29] finance, and medicine where the guild, which [11:33] is at the absolute top of the hierarchy, [11:37] both in compensation and societal prestige [11:42] is seeing its primacy threatened. [11:45] And it's going to react in this very formulaic way. [11:48] And I just saw the full spectrum of this. [11:51] I saw some people ignoring it, although we're past that. [11:55] I saw the rational rebuttal. [12:00] Sometimes really intellectually rigorous, but mostly just like, [12:03] oh, they cited the wrong study or they didn't [12:05] include a methodology section. [12:07] Give me a fucking break. [12:08] Sorry, are we allowed to curse on your pod? [12:10] Please. [12:13] And then the third is mocking them, [12:14] oh, this is a multi-billionaire and his son [12:19] has a company, Curae. [12:22] They're doing the ad hominems. [12:24] You will see the guilds respond with vigor. [12:28] Now, it was really smart to bring Zeke [12:30] into this because Zeke has such credibility. [12:34] And the combination of Vinod and Zeke and Neal [12:37] is pretty formidable. [12:39] I just think, look, I'm glad this has incited [12:42] this level of conversation. [12:44] But to me, the irreducible big thing [12:48] is we have deified our intellect and that [12:53] is the top of the hierarchy. [12:55] That's the thing that we worship in a secular society. [12:58] Suddenly, we've speciated something [13:00] that not just rivals, but in some emerging domains, and Vinod [13:05] and others point to the five cognitive functions, [13:08] we're not as good. [13:09] What do we do in this world? [13:11] What do we do economically? [13:12] What do we do sociologically? [13:14] What do we do theologically? [13:16] If you remove scarcity, what happens to the profession? [13:21] Well, it demonetizes. [13:23] The more you produce of something, [13:25] the cheaper it becomes. [13:26] Well, the more you produce of cognition and expertise, [13:29] the cheaper it becomes. [13:31] And that's great. [13:31] And you guys have been kind to listen to some of my pods. [13:34] When I did the pod with Dario Amodei, I asked him, I'm like, [13:37] look, there's 23.8 million Americans [13:39] employed in health care. [13:41] And you're talking about 50% entry level job dislocation [13:44] and 10% to 20% unemployment, what is your resolution here? [13:47] And he's like, I don't know. [13:48] I'm thinking about the patient. [13:52] Great answer. [13:54] So I think my job actually on this show with this audience [13:59] is to just provoke you both and get out of the way. [14:03] Whereas, again, it's to find a group that both [14:07] knows health care and respect and understands [14:10] the industry with you both and are both more [14:14] AI pilled than myself. [14:17] And so let me push you both on a few of these, which is, one, [14:25] I think, and just to respond quickly, I totally agree. [14:28] I'm very happy we're having this discussion now, [14:30] and it was great to have. [14:31] And I've had this discussion actually at a conference [14:34] almost a year ago. [14:35] I was pushing Zeke, and we were trying [14:36] to come up with a bet of, no, no, no, look, [14:39] this AI thing is real, patients getting empowered in this way. [14:43] And he was actually pushing me on, well, OK, Justin, [14:45] what is the bet we could make, I think [14:47] he wanted to bet a chocolate bar or something like that, [14:50] so high stakes, for what we would measure [14:53] to show that it is better, to show that patient outcomes are [14:56] better, to show that costs went down, to show something? [14:58] And I struggled with that, to be candid, a year ago. [15:01] It seems like he has evolved quite a bit in his thinking [15:04] in the power of these tools and where we're coming from this. [15:08] And so it's useful to have the discussion now [15:10] and to push all of ourselves, to push ourselves on the employment [15:13] discussions, to push ourselves on the profession, [15:15] to push ourselves on the compensation and cost. [15:18] But what are we not yet pushing ourselves [15:20] on enough yet, Matt and Eric, to you both? [15:22] And I'll bring up, Eric, you wrote this piece [15:24] on, I'm going to make a funny thing that almost [15:29] feels outdated at the moment, which I'm pushing you on of, [15:31] what? [15:32] Two months ago. [15:33] We're talking about everything coming out on this piece, [15:36] and it's just the pace of how fast things are moving. [15:40] And I know you're already writing something else. [15:42] But you wrote about this idea of Health Care's Oppenheimer [15:45] Moment, what do we need to educate people on? [15:47] Where is this going? [15:48] Matt, I know you're working on something big at the moment [15:51] to talk about, what does the future [15:53] of the academic medical center look like, these pieces? [15:56] What do we need to push ourselves on? [15:59] And it's fun. [15:59] My job now is to push you both to be unfiltered with where [16:04] you think things are going. [16:06] And I'll say, what's so hard about this [16:07] is every day, one of my jobs is, I'm running qualified health, [16:11] is to have discussions with health system leaders [16:14] and to describe where we're going. [16:16] But one of the things I struggle with is if I go too far, [16:19] then I lose people. [16:21] If I go too far into the future for what's happening, [16:24] then I lose people on-- [16:26] maybe the person I'm speaking with [16:28] will be ready there and be ready to move, [16:30] but they won't be able to convince their organization [16:32] that this is the time to make the investment, [16:35] to run, to move at this pace. [16:37] And so with that as background and context, to you [16:40] both, what are the things where you're really pushing forward? [16:44] Let's really go out there because, again, [16:46] you both are some of the people I respect most, [16:49] knowing health care and seeing where things are going. [16:51] But let's push each other, where is this really going? [16:54] What are the messages you really want [16:56] to get out to these leaders for what's coming? [16:58] Yeah. [16:59] Matt, you want to start? [17:01] Well, listen, I think there's a lot [17:04] to unpack from what you said, Justin, [17:05] because I think that going back to what we had just talked [17:08] about, there's the reality-- [17:10] again, there's some percentage of the forecasting that [17:14] is going to sound delusional because that's [17:16] what you have to do in this. [17:17] And that's been my thesis here. [17:19] But at the same time, right now as it stands today, [17:22] are our systems able to truly take advantage [17:25] of the capabilities or not? [17:28] And I think you're seeing some of this in the broader market, [17:31] in the less regulated, the less high-risk industries where [17:36] a small company with seven people who [17:38] are adept at leveraging the tools to achieve business [17:41] outcomes are running circles around the large incumbents. [17:45] The best example that we can point to recently [17:48] is the Cursor story. [17:50] Microsoft in 2024 had the OpenAI IP, they had GitHub, [17:57] and they had the leading IDE in the world, globally. [18:02] You would be insane to try to go up [18:04] against that combination of things and say, [18:06] I'm going to build a coding harness for a model [18:10] that someone else owns the IP of that's competing with me, [18:13] and I'm going to still win in the market. [18:15] It's insane to think about. [18:16] But yet, that's not how it played out. [18:18] The team was focused on their use case. [18:21] They were leveraging the technology [18:22] at every step of the way. [18:24] They didn't have any legacy things to bring along with it. [18:27] And they were able to execute in a way that's been obviously now [18:30] shown to be quite prescient. [18:32] And so how does that relate to health care? [18:34] To me, we have constructed systems, to Eric's point, [18:38] around the idea that knowledge is scarce, expertise is scarce. [18:43] And the entire academy was developed on that, [18:46] the way we teach people, the way we get evidence, [18:48] the way we do peer review. [18:50] And now we're in this environment where by the time [18:52] the paper comes out, all the technology [18:53] they were writing about is out of date. [18:55] By the time I'm trying to implement something [18:57] for a use case, there's a better version of the technology. [19:00] That is really hard to deal with in a somewhat [19:03] ossified, structured system. [19:05] That's a great point. [19:06] What do you do now? [19:07] Do you need to do-- [19:09] instead of doing a code-based shift, do you just start fresh? [19:12] Yeah. [19:13] And I think there's some people really doing [19:14] some interesting things in that space. [19:16] And Eric, I'd love to hear your point, your thoughts on this [19:18] because it really is, I think, we're [19:20] going to have to build in place, build next to almost, [19:24] as opposed to trying to pour intelligence [19:28] on a system that exist today. [19:30] Look, Matt, I really resonate with what you said. [19:33] I think about it as, look, this is, [19:35] you talked about the exponentials, [19:37] this is the most exponential technology [19:38] in the history of the world, and the obsolescence [19:41] of a framework or an idea. [19:43] And there's a lot in Oppenheimer that was only released on [19:46] June 15 that I repudiate. [19:50] And we should talk about that. [19:52] And I'm writing my new piece right now. [19:55] I thought about writing or amending Oppenheimer. [19:58] And I'm like, no, forget it. [20:00] This is just going too fast. [20:01] Now, I do think Kurtz was a great example and a $60 billion [20:06] outcome. [20:06] And I think that's illustrative of the insurgency, incumbents [20:13] versus insurgents. [20:13] And there's no more, you use the word ossified, [20:16] there's no more ossified establishment [20:21] than in health care. [20:22] I think about, we have these buildings in granite [20:25] with the stone inscriptions above the entrance. [20:30] And the AMA has existed for a century. [20:34] And the AHA is similarly deeply established. [20:41] And I find it interesting that our most prestigious [20:45] institutions, like the Cleveland Clinic and the Mayo Clinic [20:47] are also centenarians. [20:50] That's an unnatural act in this epic, [20:55] where you've got this Darwinian evolutionary competition. [21:05] So what does the most established granite sector [21:10] do when confronted with the most exponential, high-velocity tech [21:15] in history? [21:17] Well, I think you're starting to see it. [21:18] I think you're seeing this opposition. [21:22] You're seeing this resistance and this ancien régime clinging [21:32] to its prerogatives. [21:33] And I don't mean to sound dismissive or disrespectful. [21:39] I feel I'm going to get the same disintermediation as everybody [21:41] else. [21:42] This is not externalizing. [21:45] But to me, the question, Justin, that you're asking really [21:49] is the right one, which is, if the exponentials are true [21:53] and if the trajectory continues unabated, even if it slows down, [21:57] how do we prepare? [21:59] What if medical expertise really does become free or moves [22:04] asymptotically toward the cost of compute? [22:08] If you think about, what happens when the scarce resource becomes [22:14] super abundant? [22:16] The organizations that were built [22:18] to shepherd and steward and arbitrate and officiate [22:23] this scarcity, what happens to them? [22:26] When you think about a hospital as an example, let alone [22:28] a prestigious academic, hospitals are a $1.7 trillion [22:33] sector. [22:34] They have over $1 trillion in real estate. [22:37] And the idea is you get this geographically co-located, big, [22:42] sprawling installation and you aggregate multiple specialists. [22:49] And you got the gastroenterologist and [22:51] cardiometabolic specialists and the neuroscientists because you [22:53] need them all co-located because our reaction to complexity [22:58] is hyper sub-specialization. [23:00] We look at the body through a straw [23:03] because our beautiful biological brains can only [23:06] encompass so much. [23:08] And this is stylized and will be ridiculed methodologically. [23:11] But in 1950, it took 50 years for the sum total [23:14] of human medical knowledge to double. [23:16] And by some estimates, by 2019, it was 73 days. [23:19] Our reaction to cognitive overload [23:23] is to draw smaller and smaller circles around what we know. [23:26] Experts know more and more about less and less. [23:28] So we create this multi-trillion dollar bureaucracy [23:31] in these edifices to bring the specialists together. [23:36] Well, what happens at least in the cognitive domains? [23:39] I'm not talking about Optimus doing surgery or physical AI [23:42] yet. [23:43] But when that cognitive scarcity becomes cognitive abundance, [23:48] do you need this multi-trillion dollar industrial complex? [23:56] And especially, there's something really intrinsic [23:58] about LLMs in the first instantiation. [24:02] Well, they democratize expertise. [24:05] And the purpose of a corporation is to take individual experts [24:10] and aggregate them and coordinate them. [24:13] But the LLMs are arming the rebels. [24:15] They're arming the individual. [24:16] I become a polymath. [24:18] With my trusty superintelligence, [24:21] I become a lawyer and a doctor and a consultant. [24:25] And the experts can bemoan that. [24:28] And it's a jagged frontier of intelligence [24:30] and a jagged frontier of capability. [24:32] So Terry Tao isn't getting disintermediated [24:34] by this for math, even though now all the Erdős problems [24:38] are falling by the week. [24:40] I guess my point is that, Justin, [24:42] the thing I want to think about is we spend 18% of our GDP on US [24:47] health care. [24:48] We spend $6 trillion. [24:50] It's super inequitable. [24:51] Our health system is great if we're rich, white, and urban. [24:54] It's not great if you're not in one of those privileged classes. [24:57] What happens when medical expertise [25:00] becomes free and democratized? [25:03] Do the institutions that were built [25:06] to guard and meter out and arbitrate the scarcity, [25:10] do they continue to exist in their current forms? [25:14] And I would say the answer is no. [25:16] And how do we steward the transition [25:20] in a thoughtful, compassionate way? [25:21] That's what I'm thinking about. [25:23] Well, because you both brought this up at the end, [25:26] I want to push once more. [25:27] And then I know there's a couple other papers [25:29] and topics we could cover. [25:30] But you talked about, Eric, just now, [25:33] how do the institutions make the transition? [25:36] Matt, you talked about, actually, [25:39] we have to build in parallel. [25:42] And I guess, Eric, I want to push you on that. [25:44] Can the current institutions make the transitions? [25:49] And if so, what do they really have to do? [25:51] Versus, do you believe it's going [25:53] to be the insurgent, the Cursors of the world, [25:55] who are going to make this leap? [25:57] I love it. [25:58] That's right, of course. [25:59] And the Cursor-Microsoft example is very analogous. [26:05] I thought Satya was the CEO of his generation [26:07] until January of 2025 when he was at Davos. [26:14] You can point the moment that he lost $1 trillion in market cap. [26:18] He's at Davos, and Sam and Larry Ellison and Masa [26:23] are in the Roosevelt Room at the White House announcing Stargate. [26:27] And somebody at Davos interviewed Satya [26:31] about this exploding CapEx. [26:34] And Satya was like, all I know is I'm good for my $80 billion. [26:37] Microsoft lost the race in that nanosecond. [26:42] So Cursor was you went against the empire. [26:47] And now is with the most formidable entrepreneur [26:50] in the history of the world, with Elon. [26:52] The question is, can an incumbent self-disrupt? [26:56] Can an incumbent move at the speed of an insurgent? [26:59] When the insurgent is unencumbered [27:01] with legacy systems, with a lot of employment, [27:04] with having to do the change management versus just [27:06] build unencumbered, health care is the most regulated, litigious [27:14] incrementalist sector we have. [27:17] And actually, as an investor, I think about health care [27:20] as that affords you a little bit of a head start [27:22] to figure it out. [27:24] But incumbency is not some invariant law of nature. [27:27] Incumbency is a head start, what do you do with it? [27:30] And what do you do with it in this sacred, intimate space [27:34] of health care where if you move too fast, people die? [27:38] And that sounds dramatic, but it's actually quite true. [27:43] I think, if this weren't a global dynamic, [27:51] the counterfactual would be what health system or pay [27:54] or life sciences company or medtech company moves faster [27:57] than its competitors? [27:59] That's not the counterfactual. [28:00] The counterfactual is, what do the authoritarian and [28:04] monarchical regimes do? [28:06] What are you going to see in Saudi Arabia and China? [28:09] Tsinghua University opened its AI hospital. [28:11] I'm actually going to give one of the keynotes for the Dell Med [28:15] opening. [28:16] And I'm so intrigued by what we can [28:20] do if you start from first principles [28:24] and ask the question, what does AI permit us to do? [28:28] And if you don't have to rehabilitate or reconstruct [28:32] an existing organization, you can build from scratch. [28:35] Obviously, you got to work within the regulatory regime. [28:39] I do think Matt is right and you got to build in parallel. [28:44] And that's why you're starting to see a stratification. [28:46] Justin, you and I often we talk about this oligopoly of leaders, [28:51] and the 150 CEOs that have this real deterministic effect on how [28:56] things play out. [28:57] I am seeing a stratification. [28:59] You are seeing a stratification. [29:01] You're embedded with some of the real pioneering health systems. [29:04] You're starting to see some of these players [29:06] move ahead of their peers. [29:08] But too infrequently do we have a conversation about, [29:12] where are we going to be in the next several years [29:16] if the exponentials continue? [29:18] And that's why I'm so energized by the conversation we're [29:21] having right now. [29:22] My comment to this is I think about, OK, well, listen, [29:26] to your point, there's plenty of asterisks on just the reality [29:30] of the regulation. [29:31] You mentioned that there's high risk, low risk. [29:33] There's all kinds of different ways we could slice this, [29:35] but there is a hybrid analogy to the Cursor-Microsoft, which [29:39] I think is probably the sales force very recently. [29:42] So again, do I believe that that's the path? [29:45] Maybe not. [29:46] But this is a middle ground where it's like, OK, [29:50] I'm going to accept the fact that most of the things that [29:53] use software in the very near future are going to be agentic. [29:56] So we're already seeing that with the internet. [29:58] So as a software incumbent who wants [30:01] to at least maintain relevance in the exponential, [30:04] I become headless. [30:05] And I basically invite the barbarians [30:08] at the gate right on in. [30:09] And can I ride the exponential with my incumbency, [30:14] with my system of record? [30:16] And so there is a story here where-- [30:18] because I guess what you would say to this parallel idea [30:21] is, OK, there's going to be an upstart EHR that's [30:23] going to be a first principles health system, that's [30:26] going to be AI Native, and it's going [30:27] to serve health care autonomously as often as it can [30:30] and whatever it can. [30:31] That is a story that you could play out. [30:33] But I think the other version of this [30:35] is, does an Epic or an Oracle or an existing incumbent [30:39] come around to the concept of, no longer [30:42] are my users humans clicking buttons, [30:45] my users are going to be agentic? [30:46] So what do I have to do to my stack [30:49] to maintain the system of record incumbency [30:53] while also delivering the value for the change to come? [30:56] And I don't know if any system of record [30:59] is currently capable of that, but that [31:01] is another future for this where, again, it's [31:04] accepting the fact that the intelligence layer is going [31:07] to be primarily operating with each other, [31:10] meaning agent to agent and agent to software to deliver X value. [31:14] And so what does that look like for health care? [31:16] I don't know. [31:17] And the regulations boggle the mind. [31:20] Yeah. [31:22] But the regulators are trying. [31:25] They're having the discussions. [31:27] They're inviting people to the table. [31:30] Typically, regulators work with the incumbents. [31:34] The regulators are reaching out to the insurgents, [31:36] to Eric's analogies that he's using on his podcast, [31:40] on his show. [31:40] And so the regulators are moving and so [31:44] it is a very interesting dynamic. [31:47] But Eric, the one point I wanted to maybe disagree with slightly [31:50] to your point is we need to have the exponential continue [31:54] to get to this change. [31:55] And that's where I guess I'd like [31:58] to just say like we are so far. [32:01] It's a great point. [32:03] We could have a decade of implementing [32:07] the current technology to its potential [32:09] without anything improving whatsoever. [32:11] A year ago, we had more than enough to fundamentally change. [32:14] We have way more than enough right now, [32:17] without any intuition. [32:21] Yeah. [32:22] And the place to look to is just how a leading organization, [32:26] and I'll skip bringing up the slides, [32:28] but a leading organization, like an OpenAI, Anthropic, [32:31] or a Cursor-type startup is using [32:33] tools versus the median versus health care. [32:36] They are already orders of magnitude ahead [32:39] on the current tools and growing. [32:42] And so we don't need-- because I think [32:44] the conversation happening with leaders is, oh, we'll just wait. [32:46] It'll get better, or we'll see how much it gets better, [32:49] then I'll figure this out. [32:50] It's like, no, no, no, we already [32:51] have more than enough today to be [32:54] orders of magnitude ahead of where we are. [32:58] But maybe Eric, the last point. [33:00] I know we've talked about a few different things. [33:02] And we have some positivity and maybe [33:05] negativity of what's happening in the future. [33:07] Eric, you brought up this point as we [33:09] were getting ready on the cost side of health care. [33:12] I want to pull up this paper just [33:13] to make sure we can touch on it before we end today of, [33:17] are we actually already doing better? [33:18] But I'll pause here. [33:19] Jump in to whatever you want to highlight, and then I know we [33:22] have to wrap. [33:22] Yeah. [33:23] This paper everybody should read, Cutler and Klarnet. [33:27] It's a Harvard paper. [33:28] I think it's pre peer review. [33:29] It's still an archive. [33:31] This thing melted my brain. [33:33] And the idea here is that I've been promulgating this idea [33:38] that we can take 500 to 700 basis points off the percentage [33:42] of US GDP allocated to health care in just the next few years. [33:45] And I got villainized for that. [33:49] And I'm making myself a little bit unpopular in some circles [33:54] because I'm saying the quiet thing out loud, which [33:57] is, we're a $6 trillion sector, of which $3.2 trillion is labor. [34:01] We employ 23.8 million people. [34:03] One out of every six working adults is in health care. [34:05] And we suffer from Baumol's cost disease. [34:10] Productivity progress in manufacturing industrials, [34:14] even hospitality, things like that, that health care [34:19] has to compete for labor. [34:22] So we don't enjoy the productivity bump, [34:25] but we have to raise our compensation to keep people. [34:29] And as a result, we have to raise prices. [34:32] And health care has inexorably risen prices. [34:36] And so I've been saying that if AI [34:40] is an industrialization of intelligence, [34:42] and just like we saved a lot of money going from branded drugs [34:47] to generics or inpatient to outpatient site of care, [34:52] this is taking scarce cognition and making it abundant. [34:56] And when you make something in abundant, you demonetize it. [34:59] It becomes cheaper. [35:01] And so a lot of my extrapolations [35:05] about how you take 500 to 700 basis points were intuitions. [35:09] This paper says that we've already done it. [35:12] And so the paper basically says the CMS actuaries, [35:15] I'm going to go by memory, in 2010 forecasted [35:19] that by 2024, health care would consume 21.2% of the US GDP [35:29] and represent about $6.3 trillion by 2024. [35:33] The actual numbers came in $977 billion [35:36] lower and 320 basis points lower. [35:39] So instead of 21.2%, we ended at 18%. [35:43] And instead of $6.2 trillion, we came in at $5.3 trillion, [35:48] almost a trillion discrepancy. [35:50] And that over that period, that 14-year period, 2010 to 2024, [35:56] we saved $6.7 trillion that the CMS actuaries, [36:01] incorporating the projections of the ACA, predicted. [36:06] And in no 14-year period, since we started tracking the data [36:12] in 1960, have we seen this divergence. [36:16] And relative to other OECD countries, [36:20] we are actually inflecting the cost curve. [36:23] And the authors, with a lot of methodological rigor, [36:25] decompose that number. [36:27] And they say technology accounted for something [36:30] like 14% of it. [36:32] And then site of care shift and a healthier population [36:37] and the preauthorization and some of the clawbacks [36:41] from payers, it all agglomerated into this reduction. [36:45] This is all pre-AI. [36:47] And so my takeaway, Justin and Matt, is that we have a roadmap, [36:55] based on the most recent 14-year period, [36:59] for interceding and bending the cost curve. [37:03] Now, there are some mitigating things. [37:05] GLP-1's are inflationary in the first instantiation, [37:08] but they're going to be deflationary. [37:10] You guys know I'm on the board of eMed. [37:12] We're about to publish some data that [37:15] suggests that in a world of 10% medical inflation, [37:20] employees that are on GLP-1's that are adherent to it [37:24] are actually seeing a 5% drop in their total health care costs. [37:29] So most technologies in health care when they're first [37:32] introduced are inflationary because they address something [37:34] that was previously unaddressed, like a CABG, as an example. [37:37] But eventually, you're going to see more cost-effective. [37:41] A better example is total hip total knee. [37:44] So for Medicare, total hip total knee migration [37:48] from inpatient to outpatient and other site [37:51] of care shifts in 2024 accounted for $94 billion [37:55] in savings out of the $977 billion. [37:59] And so I look at this study, and I think, [38:04] this is a conceptual, theoretical roadmap for how AI. [38:09] So if you went from branded drugs [38:12] to generics and that deflation, and you went from inpatient [38:16] to outpatient and that deflation, [38:18] I said this earlier, what happens with cognition going [38:22] from a scarce to abundant? [38:25] So anyway, I would encourage everybody. [38:27] It's an 84-page paper. [38:28] It's impenetrable. [38:29] Throw it into Claude, throw it into GPT-5, 6, [38:33] or just read the damn thing because it is a seminal paper [38:37] and I'm really shocked it's not gotten a broader [38:40] readership and distribution. [38:43] Look, if Daron Acemoglu can get a Nobel Prize for basically [38:48] saying dumb stuff, like AI is not [38:51] going to affect productivity, I'm [38:54] going to nominate these two for an economics Nobel Prize. [39:00] And the best part about, I think, [39:02] this story, though, honestly, is that it's [39:06] the repercussions of a relatively blunt instrument [39:09] intervention, some major shifts, some major choices. [39:13] And then to your point about the GLPs, that also was, [39:17] let's be honest, a 20-year-old, 30-year-old drug. [39:21] So it seems like there's just so much alpha that we haven't even [39:26] taken advantage of before you get [39:28] into the discussion about what the technology is [39:30] capable of doing today. [39:31] It's fascinating to me. [39:32] And maybe this does leave us on an optimistic trajectory that, [39:37] again, Justin, to your point, the exponential stops today. [39:40] Eric, the current interventions are already bending the curve. [39:44] Maybe we do get to a place where some [39:47] of the major issues about our health system, [39:48] as you pointed out, the inequities of it [39:51] are already on the right path. [39:53] And so we have reason to leave this conversation super [39:57] optimistic. [39:58] And I think we're all headed in that direction. [40:01] Well, with that, Eric, thank you so much for joining us. [40:05] We could go on for hours and we do in other settings. [40:07] So thank you so much for being here. [40:10] And we'll talk more soon. [40:12] Thanks, gentlemen. [40:13] Thank you.